Ocular Therapeutix resubmits NDA for ocular pain relief implant

Ocular Therapeutix resubmits NDA for ocular pain relief implant

Submitted by admin on June 29, 2018 - 9:23pm
Source: 
Drug Delivery Business News
News Tags: 
Ocular Therapeutix
ocular pain relief
FDA
Dextenza
devices
Headline: 
Ocular Therapeutix resubmits NDA for ocular pain relief implant
snippet: 

Ocular Therapeutix (NSDQ:OCUL) said today that it resubmitted a new drug application for its Dextenza ocular pain relief implant to the FDA.

Do Not Allow Advertisers to Use My Personal information